MERIEUX ORAVAX has a total of 31 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ASCENDIS PHARMA OPHTHALMOLOGY DIVISION AS, EVANS-FREKE STEPHEN and GUBRA APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 3 | |
#6 | Brazil | 2 | |
#7 | Czechia | 1 | |
#8 | France | 1 | |
#9 | Hungary | 1 | |
#10 | Norway | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Guy Bruno | 17 |
#2 | Haensler Jean | 13 |
#3 | Weltzin Richard A | 10 |
#4 | Miller Charles | 6 |
#5 | Monath Thomas P | 6 |
#6 | Tomb Jean-Francois | 6 |
#7 | Kleanthous Harold | 6 |
#8 | Lee Cynthia K | 6 |
#9 | Al-Garawi Amal | 6 |
#10 | Lissolo Ling | 5 |
Publication | Filing date | Title |
---|---|---|
CA2414846A1 | Immunological combinations for prophylaxis and therapy of helicobacter pylori infection | |
FR2820424A1 | Alpa purification process | |
CA2335487A1 | Lt and ct in parenteral immunization methods against helicobacter infection | |
CA2287976A1 | Anti-helicobacter vaccine composition comprising a th1 adjuvant | |
CZ361799A3 | Use of immunogenic substance derived from bacterium of the Helicobacter strain and prevention or treatment method of infections caused by those bacteria | |
BR9809426A | Composition of anti-helicobacter vaccine for use by the subdiaphragmatic systemic route and combined mucosal / parenteral immunization method |